查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655425

全球奈米生物技术市场

Nanobiotechnology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 212 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年全球奈米生物技术市场规模将达到 1,788 亿美元

2024 年全球奈米生物技术市场规模估计为 1,194 亿美元，预计到 2030 年将达到 1,788 亿美元，2024-2030 年分析期内的复合年增长率为 7.0%。製药和生物技术最终用途产业是报告中分析的细分市场之一，预计到分析期结束时复合年增长率为 7.6%，达到 1227 亿美元。在分析期内，医疗设备最终用途部分的复合年增长率预计为 5.7%。

美国市场预计将达到 332 亿美元，中国市场复合年增长率为 6.5%

预计2024年美国奈米生物技术市场规模将达332亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 276 亿美元，2024-2030 年分析期间的复合年增长率为 6.5%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 6.6% 和 5.3%。在欧洲，德国的复合年增长率预计为 5.6%。

全球奈米薄膜市场 - 主要趋势与驱动因素摘要

什么是奈米薄膜？

奈米薄膜是一种厚度仅为几奈米的超薄膜，应用于表面可增强功能和性能。这些薄膜由多种材料製成，包括金属、陶瓷和聚合物，每种材料都具有高电导性、优异的强度、耐腐蚀性和耐磨性等独特性能。其应用领域多种多样，涵盖电子、医疗保健、能源和汽车等工业领域。例如，在电子领域，奈米薄膜可用于提高智慧型手机和电视等设备的萤幕亮度和色彩质量，从而提高其效率和性能。在医疗保健领域，奈米薄膜有助于开发更有效的药物传输系统和先进的诊断工具。

科技进步如何影响奈米薄膜的发展？

技术进步在奈米薄膜的发展中发挥着至关重要的作用，尤其是在其生产和应用方法方面。原子层沉积 (ALD)、化学气相沉积 (CVD) 和物理气相沉积 (PVD) 等技术可以精确控制这些薄膜的厚度和成分，从而能够根据特定行业需求提供量身定制的解决方案。奈米技术的创新也导致了可以对温度、光和压力等环境刺激做出反应的智慧奈米薄膜的产生。这种响应薄膜在感测器和穿戴式技术中的应用越来越广泛，它提供的自适应特性可增强装置功能和使用者互动。

哪些市场趋势将塑造奈米薄膜的未来？

奈米薄膜市场受到影响需求和供应动态的几个关键趋势的影响。一个主要趋势是对更智慧、更小型化的电子设备的需求不断增加。随着设备变得越来越小，其功能也越来越强大，对于能够在更小尺寸下发挥作用的先进材料的需求也日益增加。奈米膜透过在薄层中提供高性能来满足这些需求，使其成为小型电子设备的理想材料。另一个趋势是人们越来越关注永续性，这引起了人们对有助于提高能源效率的奈米薄膜的兴趣，例如用于太阳能电池板和节能窗户的奈米薄膜。此外，汽车产业向电动车的转变推动了对轻质、耐用材料的需求，奈米薄膜被用于延长电池寿命和提高车辆性能。

推动奈米薄膜市场成长的因素是什么？

奈米薄膜市场的成长受到多种因素的推动，例如奈米技术和材料科学的不断进步，以及奈米薄膜在各个行业中品质和适用性的提高。电子产业蓬勃发展，对更小、更快、更有效率的设备的需求不断增加，严重依赖奈米薄膜技术来满足这些需求。此外，随着世界转向更多可再生能源来源，奈米薄膜在能源领域，特别是太阳能应用领域的使用日益增多，正在支持市场的成长。尤其是随着越来越多的消费者要求产品具有良好的性能、耐用性和节能性，情况就更是如此。此外，促进环境永续性的监管趋势正在鼓励采用有助于减少环境影响的奈米薄膜等创新材料。总的来说，这些因素推动了奈米薄膜市场的蓬勃发展，反映了奈米薄膜在现代技术应用中的重要角色。

部分

最终用途（製药和生物技术产业、医疗设备）

受访企业范例（共79家）

  • Ablynx NV
  • Arrowhead Pharmaceuticals Inc.
  • CaPtivate Pharmaceuticals LLC
  • Celgene Corporation
  • ELITechGroup
  • Flamel Technologies SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • NanoBio（R）Corporation
  • Nanophase Technologies Corporation
  • pSivida Corp.
  • Sigma-Aldrich Corp.
  • Starpharma Holdings Ltd.
  • Vectura Group plc

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP-1476

Global Nanobiotechnology Market to Reach US$178.8 Billion by 2030

The global market for Nanobiotechnology estimated at US$119.4 Billion in the year 2024, is expected to reach US$178.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Industry End-Use, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$122.7 Billion by the end of the analysis period. Growth in the Medical Devices End-Use segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$33.2 Billion While China is Forecast to Grow at 6.5% CAGR

The Nanobiotechnology market in the U.S. is estimated at US$33.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Nanofilms Market - Key Trends & Drivers Summarized

What Are Nanofilms and How Are They Revolutionizing Industries?

Nanofilms are ultra-thin layers of material, often just a few nanometers thick, applied to surfaces to enhance their functionality or performance. These films can be composed of different materials, including metals, ceramics, and polymers, each offering unique properties such as high conductivity, exceptional strength, and resistance to corrosion and wear. Their applications are diverse and span across industries including electronics, healthcare, energy, and automotive. In electronics, for instance, nanofilms are used to improve the efficiency and performance of devices like smartphones and TVs by enhancing screen brightness and color quality. In the healthcare sector, nanofilms contribute to the development of more efficient drug delivery systems and advanced diagnostic tools.

How Are Technological Advancements Influencing Nanofilm Developments?

Technological advancements play a pivotal role in the development of nanofilms, particularly in the methods used for their fabrication and application. Techniques such as atomic layer deposition (ALD), chemical vapor deposition (CVD), and physical vapor deposition (PVD) allow for precise control over the thickness and composition of these films, enabling tailor-made solutions for specific industry needs. Innovations in nanotechnology have also led to the creation of smart nanofilms, which can respond to environmental stimuli such as temperature, light, and pressure. These responsive films are increasingly used in sensors and wearable technology, offering adaptive properties that enhance device functionality and user interaction.

What Market Trends Are Shaping the Future of Nanofilms?

The nanofilm market is being shaped by several significant trends that are influencing both demand and supply dynamics. One of the major trends is the increasing demand for high-performance, miniaturized electronics. As devices become smaller and their functionality increases, the need for advanced materials that can perform at these reduced dimensions grows. Nanofilms meet these requirements by enabling high performance in thin layers, making them ideal for compact electronic devices. Another trend is the growing focus on sustainability, driving interest in nanofilms that contribute to energy efficiency, such as those used in solar panels and energy-efficient windows. Additionally, the automotive industry's shift towards electric vehicles has increased the need for lightweight, durable materials, where nanofilms are used to enhance battery life and vehicle performance.

What Drives the Growth of the Nanofilm Market?

The growth in the nanofilm market is driven by several factors, including the continued advancement of nanotechnology and material science, which enhances the quality and applicability of nanofilms across various industries. The booming electronics sector, with its constant demand for smaller, faster, and more efficient devices, heavily relies on nanofilm technology to meet these requirements. Additionally, the increasing utilization of nanofilms in the energy sector, particularly in solar energy applications, supports market growth as the world moves towards more renewable energy sources. Consumer behavior also influences this growth, especially as more consumers demand high-performance, durable, and energy-efficient products. Moreover, regulatory trends promoting environmental sustainability encourage the adoption of innovative materials like nanofilms to help reduce environmental impact. These factors collectively drive the dynamic expansion of the nanofilm market, reflecting its integral role in modern technological applications.

SCOPE OF STUDY:

The report analyzes the Nanobiotechnology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceuticals & Biotechnology Industry, Medical Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 79 Featured) -

  • Ablynx NV
  • Arrowhead Pharmaceuticals Inc.
  • CaPtivate Pharmaceuticals LLC
  • Celgene Corporation
  • ELITechGroup
  • Flamel Technologies SA
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • NanoBio(R) Corporation
  • Nanophase Technologies Corporation
  • pSivida Corp.
  • Sigma-Aldrich Corp.
  • Starpharma Holdings Ltd.
  • Vectura Group plc

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Nanobiotechnology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Nanotechnology Propel Growth in Nanobiotechnology Market
    • Increasing Demand for Targeted Drug Delivery Expands Addressable Market Opportunity
    • Growth in Diagnostic and Imaging Applications Generates Demand for Nanobiotechnology Solutions
    • Technological Innovations in Nanomedicine Strengthen Business Case for Nanobiotechnology
    • Integration of Nanomaterials in Regenerative Medicine Spurs Growth in Healthcare Sector
    • Demand for Precision Medicine Expands the Market for Nanobiotechnology
    • Advances in Nano-Scale Imaging and Sensing Technologies Generate Demand for Innovative Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nanobiotechnology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nanobiotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceuticals & Biotechnology Industry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pharmaceuticals & Biotechnology Industry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: USA 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: Canada 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: Japan 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: China 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Nanobiotechnology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Europe 15-Year Perspective for Nanobiotechnology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: France 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Germany 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Italy 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: UK 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 41: Rest of Europe Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Rest of Europe Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Rest of Europe 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Nanobiotechnology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 44: Asia-Pacific Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Asia-Pacific Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Asia-Pacific 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 47: Rest of World Recent Past, Current & Future Analysis for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of World Historic Review for Nanobiotechnology by End-Use - Pharmaceuticals & Biotechnology Industry and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of World 15-Year Perspective for Nanobiotechnology by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals & Biotechnology Industry and Medical Devices for the Years 2015, 2025 & 2030

IV. COMPETITION